N,N'-Bis(2-chloroethyl)-N-nitrosourea (BCNU)-induced apoptosis of neural progenitor cells in the developing fetal rat brain

Journal of Toxicologic Pathology

Volumn 23, Issue 1, 2010, Pages 25-30

  Yamaguchi, Tsuyoshi ^a,b   Kanemitsu, Hiroyuki ^a   Yamamoto, Satoshi ^a   Komatsu, Masahiko ^a   Uemura, Hiroyuki ^a   Tamura, Kazutoshi ^a   Shirai, Tomoyuki ^b  

^a Research Center Inc   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Apoptosis; BCNU; Fetal brain; Neural progenitor cells; Rat

Indexed keywords

CARMUSTINE; CASPASE 3; CELL PROTEIN; HISTONE H3; PROTEIN IBA1; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN TOXICITY; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; MICROGLIA; MITOSIS RATE; NERVE CELL INHIBITION; NEURAL STEM CELL; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 77953652742     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.23.25     Document Type: Article

References (22)

1. Walker MD and Hurwitz BS. BCNU (1,3-bis(2- chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor-a preliminary report. Cancer Chemother Rep. 54: 263-271, 1970.
2. Bodell WJ, Giannini DD, Hassenbusch S, and Levin VA. Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors. Neuro Oncol. 3: 241-245. 2001.
3. Linfoot PA, Gray JW, Dean PN, Marton LJ, and Deen DF. Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate. Cancer Res. 46: 2402-2406. 1986.
4. Bodell WJ, Gerosa M, Aida T, Berger MS, and Rosenblum ML. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Cancer Res. 45: 3460-3464. 1985.
5. Rao MS. Multipotent and restricted precursors in the central nervous system, Anat. Rec. 261: 139-140. 2000.
6. Moroni RF, Inverardi F, Regondi MC, Panzica F, Spreafico R, and Frassoni C. Altered spatial distribution of PV-cortical cells and dysmorphic neurons in the somatosensory cortex of BCNU-treated rat model of cortical dysplasia. Epilepsia. 49: 872-887. 2008.
7. Benardete EA and Kriegstein AR. Increased excitability and decreased sensitivity to GABA in an animal model of dysplastic cortex. Epilepsia. 43: 970-982. 2002.
8. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, and Flavell RA. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384: 368-372. 1996.
9. Keramaris E, Stefanis L, MacLaurin J, Harada N, Takaku K, Ishikawa T, Taketo MM, Robertson GS, Nicholson DW, Slack RS, and Park DS. Involvement of caspase 3 in apoptotic death of cortical neurons evoked by DNA damage. Mol Cell Neurosci. 15: 368-379. 2000.
10. Ihara T, Yamamoto T, Sugamata M, Okumura H, and Ueno Y. The process of ultrastructural changes from nuclei to apoptotic body. Virchows Arch. 433: 443-447. 1998.
11. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 88: 323-331. 1997.
12. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, and Reed SI. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76: 1013-1023. 1994.
13. Polyak K, Waldman T, He TC, Kinzler KW, and Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10: 1945-1952. 1996.
14. Lu DP, Nakayama H, Shinozuka J, Uetsuka K, Taki R, and Doi K. 5-Azacytidine-induced apoptosis in the central nervous system of developing rat fetuses. J. Toxicol. Pathol. 11: 133-136. 1998.
15. Ueno M, Katayama K, Yasoshima A, Nakayama H, and Doi K. 5-Azacytidine (5AzC)-induced histopathological changes in the central nervous system of rat fetuses. Exp. Toxicol. Pathol. 54: 91-96. 2002.
16. Katayama K, Ishigami N, Uetsuka K, Nakayama H, and Doi K. Ethylnitrosourea (ENU)-induced apoptosis in the rat fetal tissues. Histol Histopathol. 15: 707-711. 2000.
17. Nam C, Woo GH, Uetsuka K, Nakayama H, and Doi K. Histopathological changes in the brain of mouse fetuses by etoposide-administration. Histol Histopathol. 21: 257-263. 2006.
18. Woo GH, Katayama K, Jung JY, Uetsuka K, Bak EJ, Nakayama H, and Doi K. Hydroxyurea (HU)-induced apoptosis in the mouse fetal tissues. Histol Histopathol. 18: 387-392, 2003.
19. Yamauchi H, Katayama K, Ueno M, Uetsuka K, Nakayama H, and Doi K. Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced rat fetal brain lesions. Neurotoxicol Teratol. 26: 579-586. 2004.
20. Kanemitsu H, Yamauchi H, Komatsu M, Yamamoto S, Okazaki S, and Nakayama H. Time-course changes in neural cell apoptosis in the rat fetal brain from dams treated with 6-mercaptopurine (6-MP). Histol Histopathol. 24: 317-324. 2009.
21. Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, Brinkley BR, Bazett-Jones DP, and Allis CD. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma. 106: 348-360. 1997.
22. Ueno M, Katayama K, Yamauchi H, Yasoshima A, Nakayama H, and Doi K. Repair process of fetal brain after 5-azacytidine-induced damage. Eur J Neurosci. 24: 2758-2768. 2006.